阴道菌群失调与人乳头瘤病毒感染及宫颈癌风险:系统综述与荟萃分析
该系统综述纳入15项主要为前瞻性队列的研究、共101049名女性,评估阴道菌群失调对人乳头瘤病毒(HPV)感染、持续感染及宫颈病变的影响。荟萃分析显示,阴道菌群失调与发生HPV感染、HPV持续感染及高级别病变和癌症的风险升高相关。
要点
- 阴道菌群失调与发生HPV感染风险升高相关(总体RR 1.33,95%CI 1.18-1.50,I²=0%)。
- 阴道菌群失调与HPV持续感染风险升高相关(总体RR 1.14,95%CI 1.01-1.28,I²=44.2%)。
- 阴道菌群失调与高级别病变和癌症风险升高相关(RR 2.01,95%CI 1.40-3.01,I²=0%)。
核心结论
- 本研究支持阴道菌群失调与宫颈癌之间存在因果联系,沿致癌性HPV获得、持续感染及宫颈阴道发育不良 pathway 发展。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、CINAHL、Cochrane Library和Web of Science(自建库至2018年6月),方案注册于PROSPERO(CRD42016035620)。
- 纳入15项主要为前瞻性队列的研究,发表于2003年至2017年,共包括101049名女性。
主要发现
- 阴道菌群失调与发生HPV感染风险升高相关(总体RR 1.33,95%CI 1.18-1.50,I²=0%);年轻女性中RR 1.43,95%CI 1.10-1.85,I²=0%。
- 阴道菌群失调与HPV持续感染风险升高相关(总体RR 1.14,95%CI 1.01-1.28,I²=44.2%);致癌型别中RR 1.18,95%CI 1.01-1.38,I²=0%。
- 阴道菌群失调与高级别病变和癌症风险升高相关(RR 2.01,95%CI 1.40-3.01,I²=0%),但病变/癌症女性与无病变/癌症女性比较,不论其致癌性HPV状态。
- 总体上,分子阴道菌群研究也发现了可比的结果。
局限性
- 病变/癌症女性与无病变/癌症女性比较,不论其致癌性HPV状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The vaginal microbiota proposedly influence the association between human papillomavirus and cervical cancer. Our aim was to assess whether vaginal dysbiosis affects human papilloma virus acquisition, persistence, and progression to related cervical premalignancy. DATA SORUCES: MEDLINE, Embase, CINAHL, Cochrane Library, and Web of Science (inception until June 2018) were used for this study. The study protocol was registered at PROSPERO (CRD42016035620). STUDY ELIGIBILITY CRITERIA: This systematic review included all observational studies reporting on incident human papilloma virus, persistent human papilloma virus, and/or related cervical disease in women with or without vaginal dysbiosis prior to outcome assessment. STUDY APPRAISAL AND SYNTHESIS METHODS: We used random-effects models for meta-analyses and report pooled relative risks with 95% confidence intervals. The risk for incident and/or persistent human papilloma virus or related cervical disease based on longitudinal results was determined. RESULTS: Of 1645 unique articles, 15 mainly prospective cohort studies were included, published between 2003 and 2017, including a total of 101,049 women. Vaginal dysbiosis was associated with an increased risk of incident human papilloma virus (overall relative risk, 1.33, 1.18-1.50, I2 = 0%; among young women relative risk, 1.43, 1.10-1.85, I2 = 0%), human papilloma virus persistence (overall relative risk, 1.14, 1.01-1.28, I2 = 44.2%; for oncogenic types relative risk, 1.18, 1.01-1.38, I2 = 0%), and high-grade lesions and cancer (relative risk, 2.01, 1.40-3.01, I2 = 0%), but women with lesions/cancer were compared with those without, regardless of their oncogenic human papilloma virus status. Overall, comparable results were found in the molecular vaginal microbiota studies. CONCLUSION: This study supports a causal link between vaginal dysbiosis and cervical cancer along the oncogenic human papillomavirus acquisition, persistence, and cervicovaginal dysplasia development pathway.
引用
- Brusselaers N, Shrestha S, van de Wijgert J, et al. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2018. PMID: 30550767. doi:10.1016/j.ajog.2018.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。